PFE (Pfizer Inc.) Expected net earnings per share growth this year

PFE (Pfizer Corp) - company brandmark

Large-scale clinical trials and the colossal budgets of Pfizer Inc. (PFE) ensure stability, which the annual earnings per share trajectory links to operational efficiency. Investments in biotech startups and oncology are designed to refresh the portfolio, while the current pivot and cost optimization combat declining revenues. The value of -5.60 shows the current volume of the metric, capturing the result of this restructuring.

PFE - Pfizer Earnings growth in current year over the range 07/04/2022 - 11/10/2026

Financial and market metric breakdowns for Pfizer Inc. (PFE)

- stock quotes and analyst forecast:
Share Price Pfizer Inc|PFE - Analyst Consensus Forecast
- business market valuation indicators:
Market Capitalization Pfizer Corp|PFE - Total Company Value
- shareholders' equity book value data:
Equity per Share Pfizer|PFE - Book Capitalization|Market Value to Equity Ratio pfizer.com|PFE - Aggregate Company Assets
- debt and liquidity details:
Aggregate Debt to Equity Pfizer Inc.|PFE - Long-Term Debt to Capital|Current Liabilities to Equity pfizer.com|PFE - Company Aggregate Debts|Debts to Net Assets Pfizer Corp|PFE - Company Long-Term Liabilities|Current Liabilities Pfizer|Immediate Liquidity pfizer.com
- earnings and market ratios statistics:
PFE - Company Net Income|Expected Net Income Pfizer Inc.|PFE - Price to Earnings Ratio|Future Price to Earnings Multiple Pfizer Corp|PFE - PEG Multiple|Total Company Value to Operating Income Before Depreciation Ratio Pfizer Corp|PFE - Profit before payment of interest, taxes and amortization|Earnings per share for the last 12 months Pfizer|PFE - Net earnings per share (EPS TTM)|Year-over-year net earnings per share growth for the last 12 months pfizer.com|PFE - Net earnings per share growth this year|Consensus forecast of earnings per share growth for next year Pfizer Inc.
Fundamental valuation:PFE - Pfizer Inc
Product sample of Pfizer Corp

This indicator measures the annual growth of earnings per share, allowing investors to assess the growth rate of the business's real income and identify phases of market overheating. By analyzing the history of annual net income growth per share, one can determine how effectively Pfizer Inc. (PFE) optimizes costs through the outsourcing of production and logistics to scale profits against operating expenses.

Key competitors

Earnings per share growth this year LLY|ABBV (Abbvie) - Earnings growth in current year|AstraZeneca Corp. (AZN) - Expected net earnings per share growth this year|Earnings per share growth in current year Novartis AG (NVS)|merck.com - Earnings per share growth this year|Earnings growth in current year NVO (Novo Nordisk)|Net earnings per share change in current year Amgen Corp|SNY - Earnings per share growth in current year|Earnings per share trend in current year BMY|GSK: Earnings growth in current year|Earnings per share trend in current year TAK (takeda.com)|TEVA (Teva Pharmaceuticals) - Earnings growth in current year|Dr. Reddy's Laboratories Limited (RDY) - Expected net earnings per share growth this year|Net earnings per share growth this year VTRS (Viatris Corp)|ROIV: Earnings per share trend in current year|Earnings growth in current year ZLAB (Zai Lab Limited)|bauschhealth.com (BHC) - Earnings per share growth rate in current year|COSM - Earnings per share growth in current year